Patents
Patents for C07C 237 - Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups (16,118)
04/2011
04/07/2011US20110082087 Compounds for treating pain
04/06/2011EP2305637A2 Substituted tetracycline compounds
04/06/2011EP2303831A2 Solid states of aliskiren free base
04/06/2011EP1303479B1 7-, 8- and 9-substituted tetracycline compounds
04/06/2011CN102001965A Synthesis of iodixanol in water
04/06/2011CN102001964A Method for preparing gadodiamide
04/05/2011US7919529 δ-amino-γ-hydroxy-ω-aryl-alkanoic acid amides
04/05/2011US7919454 Methods of treating using conjugates transported by a PEPT2 transporter
03/2011
03/31/2011WO2011037833A2 Novel n-benzylamide substituted derivatives of 2-(acylamido)acetic acid and 2-(acylamido)propionic acids: potent neurological agents
03/31/2011US20110077225 4-Substituted Tetracyclines and Methods of Use Thereof
03/31/2011US20110077216 Compositions and methods for the treatment of atherosclerosis and other related diseases
03/31/2011CA2774569A1 Novel n-benzylamide substituted derivatives of 2-(acylamido)acetic acid and 2-(acylamido)propionic acids: potent neurological agents
03/30/2011EP2301915A1 7-(diethylamino)methyl substituted tetracycline having target therapeutic activities
03/30/2011EP2301914A1 7,9-Substituted tetracycline compounds
03/30/2011EP2301913A1 7,9-Substituted tetracycline compounds
03/30/2011EP2301912A2 4-aminotetracyclines and methods of use thereof
03/30/2011EP2301550A1 Tetracycline compounds having target therapeutic activities
03/30/2011EP2301534A1 Amino-methyl substituted tetracycline compounds
03/30/2011EP0933354B1 Calcium receptor-active compounds
03/29/2011US7915450 Transfection reagents
03/29/2011US7915420 Aryl piperidine amides
03/24/2011WO2011034078A1 Glycine compound
03/24/2011WO2011032277A1 Quinazolinone derivatives as viral polymerase inhibitors
03/24/2011WO2010131922A3 Amide compound, preparation method thereof and pharmaceutical composition comprising same
03/24/2011WO2010043953A3 Novel bridged cyclic compounds as histone deacetylase inhibitors
03/24/2011CA2772689A1 Glycine compound
03/23/2011EP2298732A1 7,9-Substituted tetracycline compounds
03/23/2011EP2298731A1 Amide compound
03/23/2011EP2298728A1 Transfection reagents
03/23/2011EP2298323A2 Substituted tetracycline compounds
03/23/2011EP2298322A2 Substituted tetracycline compounds
03/23/2011EP2297397A1 Chemical and method for chelating metal ions included in water and separating/recovering of formed chelate
03/23/2011EP2297092A1 Polymorphic and amorphous forms of lacosamide and amorphous compositions
03/23/2011EP2297088A2 New compounds with activity that protects against the action of toxins and viruses in intracellular action mode
03/23/2011EP2296464A1 Salts and polymorphs of a tetracycline compound
03/22/2011CA2432572C Oxybenzamides derivatives as factor xa inhibitors
03/17/2011US20110065904 H3lmn compound used as radioactive agent for treatment of liver cancer and manufacturing method thereof
03/17/2011US20110065850 Compounds suitable for use in inks and inks having such compounds
03/16/2011EP2295404A2 Substituted tetracycline compounds
03/16/2011EP2295401A2 Deuterated hepatitis C protease inhibitors
03/16/2011EP2025661B1 Fluoroalkyloxy-containing combretastatin derivatives, preparation and use thereof
03/16/2011EP1420010B1 Amphoteric lipid compound and use thereof
03/16/2011CN101985428A O-anilino benzoic acid derivatives or pharmaceutically acceptable salts thereof as well as preparation method and application thereof
03/10/2011WO2011028919A2 Solid forms of aliskiren hemifumarate and processes for preparation thereof
03/10/2011WO2011027888A1 Diamide-phenyl derivative and pharmaceutically acceptable salt thereof
03/10/2011WO2011027106A1 Therapeutic aryl-am i do-aryl compounds and their use
03/10/2011WO2011026781A1 Novel multifunctional peptidase inhibitors, especially for medical use
03/10/2011US20110060081 Compounds suitable for use in inks and inks having such compounds
03/10/2011CA2772975A1 Novel multifunctional peptidase inhibitors, especially for medical use
03/10/2011CA2771097A1 Therapeutic aryl-amido-aryl compounds and their use
03/09/2011EP2292608A1 Intermediates for the preparation of substituted Aminosalicylic acid amides with fungicidal activity
03/09/2011EP2292590A2 Prodrugs of 9-aminomethyl tetracycline compounds
03/09/2011EP2292589A1 Novel multifunctional peptidase inhibitors, especially for medical use
03/09/2011EP0907625B1 Method for separating organic compounds using fluorous separation systems
03/03/2011WO2011025982A2 Tetracycline compounds
03/03/2011WO2011024184A1 Dialkyldiaza-tetraalkyloctane diamide derivatives useful for the separation of trivalent actinides from lanthanides and process for the preparation thereof
03/03/2011WO2011022805A1 Novel colchicine derivatives, methods and uses thereof
03/03/2011US20110053858 Heterocyclic peptide ketoamides
03/03/2011US20110053848 Prodrug comprising a drug linker conjugate
03/03/2011US20110052552 Compositions to effect neuronal growth
03/03/2011US20110052513 Cationic surfactant compounds, use thereof as conditioner, cosmetic treatment method, and cosmetic or pharmaceutical compositions comprising same
03/03/2011US20110052504 Contrast agents
03/03/2011US20110052492 Radiohalogenated Benzamide Derivatives And Their Use In Tumor Diagnosis And Tumor Therapy
03/03/2011CA2808277A1 Novel colchicine derivatives, methods and uses thereof
03/03/2011CA2772386A1 Tetracycline compounds
03/02/2011EP2289962A2 Polyurea compositions and compounds for the preparation thereof
03/02/2011EP2289888A2 Epoxycarboxylic acid amides, azides and amino alcohols and processes for preparation of alpha-keto amides by using them
03/02/2011EP2289887A2 Epoxycarboxylic acid amides, azides and amino alcohols and processes for preparation of alpha-keto amides by using them
03/02/2011EP2289871A1 7-substituted tetracycline compounds
03/02/2011EP2289870A1 Method for purifying 5-amino-N,N'-bis(2,3-dihydroxypropyl)-isophthalamide, an intermediate in the preparation of non-ionic X-ray contrast agents
03/02/2011EP2288615A1 Selective caspase inhibitors and uses thereof
02/2011
02/24/2011WO2010129057A8 Tetracycline compounds
02/24/2011US20110046346 Biomaterial with functionalised surfaces
02/24/2011US20110046138 Novel compounds advantageous in the treatment of central nervous system diseases and disorders
02/24/2011US20110046129 2-Phenylethylamino Derivatives as Calcium and/or Sodium Channel Modulators
02/24/2011US20110046128 Novel compounds advantageous in the treatment of central nervous system diseases and disorders
02/24/2011US20110041732 Process for manufacturing asphalt
02/23/2011EP2287153A1 Synthesis Of Renin Inhibitors Involving A Cycloaddition Reaction
02/23/2011EP2287148A2 Substituted tetracycline compounds
02/23/2011EP2287140A2 Substituted tetracycline compounds
02/23/2011EP2285772A2 New class of cationic lipids for transporting active agents into cells
02/23/2011EP0947500B1 Sulfonamide derivatives and drugs containing the same as the active ingredient
02/23/2011CN1419537B Insecticidal anthranilamides
02/23/2011CN101979376A Method for preparing glycinamide hydrochloride
02/22/2011US7893282 7-substituted fused ring tetracycline compounds
02/22/2011CA2350882C Transfection reagents
02/17/2011WO2011019393A2 Class- and isoform-specific hdac inhibitors and uses thereof
02/17/2011US20110040123 Bifunctional compound containing amino group and diaminedithiol ligand and manufacturing method thereof
02/17/2011US20110039851 Ccr10 antagonists
02/17/2011US20110039819 Substituted phenoxybenzamides
02/17/2011US20110039714 Probes, Systems, and Methods for Drug Discovery
02/17/2011US20110039682 Method for synthesizing one-dimensional helical nanoporous structures and method for synthesizing glycine-derived surfactant for synthesizing helical nanoporous structures
02/17/2011CA2770896A1 Cathepsin c inhibitors
02/17/2011CA2770801A1 Pesticidal carboxamides
02/16/2011EP2284153A2 Substituted tetracycline compounds
02/16/2011EP2284152A2 Substituted tetracycline compounds
02/16/2011EP2284151A2 Substituted tetracycline compounds
02/16/2011EP2284150A2 Substituted tetracycline compounds
02/16/2011EP2284149A1 Selective androgen receptor modulators and methods of use thereof
02/16/2011EP2282982A1 Novel [f-18]-labelled l-glutamic acid- and l-glutamine derivatives (i), use thereof and method for their production
1 ... 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 ... 162